Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice
- PMID: 286835
Item in Clipboard
Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice
J Natl Cancer Inst.
1979 Jul.
No abstract available
Similar articles
-
Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.Cancer Res. 1977 Jun;37(6):1719-26. Cancer Res. 1977. PMID: 66985
-
In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.Cancer Res. 1977 Mar;37(3):815-20. Cancer Res. 1977. PMID: 837378
-
Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.Cancer Res. 1973 Aug;33(8):1837-44. Cancer Res. 1973. PMID: 4720795 No abstract available.
-
Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.Cancer Invest. 1984;2(1):39-49. doi: 10.3109/07357908409020285. Cancer Invest. 1984. PMID: 6322938 Review. No abstract available.
-
Immunochemotherapy of human cancer.Semin Oncol. 1974 Dec;1(4):409-23. Semin Oncol. 1974. PMID: 4620443 Review. No abstract available.
Cited by
-
Identification of Caspase-6 as a New Regulator of Alternatively Activated Macrophages.J Biol Chem. 2016 Aug 12;291(33):17450-66. doi: 10.1074/jbc.M116.717868. Epub 2016 Jun 20. J Biol Chem. 2016. PMID: 27325699 Free PMC article.
-
Tumour response to chemotherapy in animals that have been treated with the same drugs prior to tumour implantation: a model for studying host effects on apparent drug resistance.Br J Cancer. 1988 Aug;58(2):133-8. doi: 10.1038/bjc.1988.179. Br J Cancer. 1988. PMID: 3166902 Free PMC article.
-
Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and Neutrophils.Front Oncol. 2022 May 19;12:871513. doi: 10.3389/fonc.2022.871513. eCollection 2022. Front Oncol. 2022. PMID: 35664746 Free PMC article. Review.
-
Systemic activation of macrophages by liposome-entrapped muramyl tripeptide in mice pretreated with the chemotherapeutic agent adriamycin.Cancer Immunol Immunother. 1982;14(2):61-6. doi: 10.1007/BF00200168. Cancer Immunol Immunother. 1982. PMID: 6965228 Free PMC article.
-
Macrophages are critical effectors of antibody therapies for cancer.MAbs. 2015;7(2):303-10. doi: 10.1080/19420862.2015.1011450. MAbs. 2015. PMID: 25667985 Free PMC article. Review.